Law Firm Probes Option Care Health Over Shareholder Rights
Monteverde & Associates is investigating Option Care Health amid potential shareholder concerns. The M&A-focused class action firm has recovered millions for investors.
A New York-based class action law firm has launched an investigation into Option Care Health, Inc. (NASDAQ: OPCH), scrutinizing whether the home infusion therapy company's leadership acted in shareholders' best interests, according to an announcement from Monteverde & Associates PC.
Attorney Juan Monteverde, whose firm specializes in mergers and acquisitions litigation, is leading the inquiry. Monteverde & Associates was recognized as a Top 50 firm in the 2025 ISS Securities Class Action Services Report, a benchmark that tracks performance and recovery records across the securities litigation industry.
Read more Law Firm Investigates Option Care Health Over Shareholder Rights →
The firm has a stated track record of recovering millions of dollars on behalf of shareholders in similar investigations, typically examining whether corporate boards fulfilled their fiduciary duties during transactions or other significant corporate events. Option Care Health, which trades on the Nasdaq under the ticker OPCH, has not yet issued a public response to the investigation announcement.
Shareholder investigations of this kind often precede formal litigation and are intended to determine whether investors suffered harm as a result of corporate decisions or disclosures. Shareholders who hold or previously held OPCH stock may have legal options depending on findings that emerge from the probe.
Continue reading at All Financial Services & Investing
